266 filings
Page 8 of 14
8-K
rkr08b8 b8bgad5
17 Dec 20
Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Topiramate Oral Solution
9:17am
8-K
xxb9u glmdx0jhnm
24 Nov 20
Eton Pharmaceuticals Announces Availability of Orphan Drug ALKINDIĀ® SPRINKLE (hydrocortisone) in the United States
4:38pm
4
74hflnq b29j0k
16 Oct 20
Change in insider ownership
9:30pm
8-K
68qsqopr6y6l rdnmbv
16 Oct 20
Eton Pharmaceuticals Announces Closing of Public Offering
5:24pm
424B5
yx6kf5
15 Oct 20
Prospectus supplement for primary offering
4:50pm
8-K
dew2hddz7oundx7 hqc
15 Oct 20
Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Zonisamide Oral Suspension
9:15am
8-K
ruil5by16pm
14 Oct 20
Eton Pharmaceuticals Announces Proposed Public Offering of Common Stock
8:53am
424B5
1ehez
13 Oct 20
Prospectus supplement for primary offering
4:21pm
8-K
d92yi
8 Oct 20
Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Orphan Drug Dehydrated Alcohol Injection
9:05am
8-K
5yfphk1 en
6 Oct 20
Other Events
4:56pm
8-K
wmw4r3okmwzyir
30 Sep 20
Other Events
6:15am
8-K
xaajxka1
25 Sep 20
Other Events
8:23am
8-K
zsai 1wthk
16 Sep 20
Eton Pharmaceuticals Provides Update on the FDA Review of EM-100
9:28am
8-K
kgfctmv2q1040r6vlbc
31 Aug 20
Eton Pharmaceuticals Announces Appointment of Ingrid Hoos as Senior Vice President of Scientific Affairs
9:25am
EFFECT
q77w12cimcy
26 Aug 20
Notice of effectiveness
12:15am
CORRESP
9lfbznm7g0vvct6x
24 Aug 20
Correspondence with SEC
12:00am
8-K
fl4to3s00y7
12 Aug 20
Eton Pharmaceuticals Announces Second Quarter 2020 Financial Results
8:52am
8-K
tiequzr22kn0j zm00j
11 Aug 20
Eton Pharmaceuticals Provides Update on the FDA Review of EM-100
9:21am